References:

1 Orbach D,Rey A,Cecchetto G,et al.Infantile fibrosarcoma: management based on the European experience[J].J Clin Oncol,2010,28(2):318-323.DOI:10.1200/JCO.2009.21.9972.
2 Sultan I,Casanova M,Aljumaily U,et al.Soft tissuesar-comas in the first of life[J].Eur J Cancer,2010,46(13):2449-2456.DOI:10.1016/j.ejca.2010.05.002.
3 Kampp J,Husain AN.Pathologic Quic Case: newborn with a subeutaneous facial mass[J].Arch Pathol Lab Med,2003,127(6):281-282.DOI:10.1043/1543-2165(2003)1272.0.CO;2.
4 Chung EB,Enzinger FM.Infantile fibrosarcoma[J].Cancer,1976,38(2):729-739.DOI:10.1002/1097-0142(197608)38:23.0.CO;2-Z.
5 Kanack M,Collins J,Fairbanks TJ,et al.Congenital-infantile fibrosarcoma presenting as a hemangioma: a case report[J].Ann Plast Surg,2014,74: S25-S29.DOI:10.1097/SAP.0000000000000376.
6 Surico G,Muggeo P,Daniele RM,et al.Chemotherapy alone for the treatment of congenital fibrosarcoma: is surgery always needed?[J].Med Pediatr Oncol,2003,40(4):268-270.DOI: 10.1002/mpo.10150.
7 Orbach D,Brennan B,De Paoli A,et al.Conservative strategy in infantile fibrosarcoma is possible: the European Paediatric Soft Tissue Sarcoma Study Group experience[J].Eur J Cancer,2016,(57):1-9.DOI:10.1016/j.ejca.2015.12.028.
8 邹继珍,何傯,白云,等.婴儿型纤维肉瘤的临床病理分析[J].中国小儿血液与肿瘤杂志,2017,22(1):18-23.DOI:10.3969/j.issn.1673-5323.2017.01.005. Zou JZ,He C,Bai Y,et al.Clinicopathological analysis of infantile fibrosarcoma[J].China Pediatr Blood Cancer,2017,22(1):18-23.DOI:10.3969/j.issn.1673-5323.2017.01.005.